MedTrace Logo

MS Relapses During COVID-19 Pandemic

NCT04858763 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 51

Last updated 2026-03-19

No results posted yet for this study

Summary

Throughout the COVID-19 pandemic, and to our knowledge there have been no studies looking systematically at the occurrence of MS relapses and their subsequent management, during the peak of the first wave of the pandemic. In this study we will explore how MS relapses were reported and managed during April - June 2020, compared to a control cohort who experienced a relapse during the same period in 2019 across 5 UK centers.

Conditions

Interventions

OTHER

No Intervention

There will be no intervention during this study.

Sponsors & Collaborators

  • Nottingham University Hospitals NHS Trust

    lead OTHER

Principal Investigators

  • Nikos Evangelou · University of Nottingham

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-07-01
Primary Completion
2022-06-28
Completion
2023-06-20

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04858763 on ClinicalTrials.gov